Reverse Recapitalization - Schedule of Stockholders' Equity (Parenthetical) (Details) - USD ($) $ in Thousands |
9 Months Ended | ||
|---|---|---|---|
Apr. 06, 2026 |
Sep. 30, 2026 |
Dec. 31, 2025 |
|
| Business Combination [Line Items] | |||
| Payments for Repurchase of Warrants | $ 56,700 | ||
| Common Class B [Member] | |||
| Business Combination [Line Items] | |||
| Common Stock, Value, Issued | $ 2 | $ 1 | |
| Common Stock, Shares, Issued | 24,146,609 | 11,551,903 | |
| Haymaker [Member] | |||
| Business Combination [Line Items] | |||
| Settlements Consist | $ 10,500 | ||
| Transaction Costs | 25,900 | ||
| Payment Under The Non-Redemption Agreements | $ 3,700 |
| X | ||||||||||
- Definition Amount of transaction cost incurred to effect business combination. Excludes separately recognized transaction and indirect cost. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount paid by the entity to reacquire the right to purchase equity shares at a predetermined price, usually issued together with corporate debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cash received for the settlement of litigation during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after the effects of master netting arrangements, of funds outstanding loaned in the form of a security resale agreement between the entity and another party for the purchase and resale of identical or substantially the same securities at a date certain for a specified price. Includes purchases of participations in pools of securities that are subject to a resale agreement, assets not subject to a master netting arrangement and not elected to be offset. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|